Procter & Gamble Health Limited

NSE BSE

Performance

Today's Low		Today's High
5,555.00 5,538.25		5,642.45 5637.40

52 Week Low		52 Week High
4,636.55 (25-Apr-2024) 4,640.30 (09-May-2024)		5,833.30 (06-Nov-2024) 5,835.95 (06-Nov-2024)

Open: 5,642.00 5,600.00

Previous Close: 5,642.00 5,642.25

Volume: 0.06

Total Traded value: 3.28 (₹ Lakhs)

Upper circuit: 6,770.40 6,178.50

Lower circuit: 4,513.60 4,119.00

Market Depth

Buy Order Quantity		Sell Order Quantity
0		1

Bid Price	Quantity
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	--

Ask Price	Quantity
5,604.75	1.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	1

Fundamentals

Market Cap:	₹93.12 Cr
PE Ratio (TTM):	42.22
PB Ratio:	17.08
Industry P/E:	41.33
Debt to Equity:	0.00

ROE:	40.45
EPS (TTM):	131.17
Book Value:	0.00
Face Value:	10.00

Financials

	Sep, 2023	Jun, 2023	Mar, 2023	Dec, 2022	Sep, 2022
Revenue	304.93 Cr	301.18 Cr	320.92 Cr	309.97 Cr	297.55 Cr
Profit	65.57 Cr	29.82 Cr	59.19 Cr	76.80 Cr	63.66 Cr
Expense	222.93 Cr	262.51 Cr	247.36 Cr	209.57 Cr	214.37 Cr
Comprehensive income	65.06 Cr	30.26 Cr	60.96 Cr	72.58 Cr	63.83 Cr
EPS	39.50	17.96	35.70	46.30	38.30

Procter & Gamble Health Limited is a leading manufacturer and distributor of pharmaceuticals and chemicals in India. With a wide range of over-the-counter products, vitamins, minerals, and supplements, the company caters to the diverse healthcare needs of the Indian market. Its renowned brands include Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas.

In addition to serving the domestic market, Procter & Gamble Health Limited also exports its high-quality pharmaceutical products to neighboring countries such as Sri Lanka, Nepal, Myanmar, and Maldives. This demonstrates the company's commitment to expanding its reach and contributing to the well-being of people beyond Indian borders.

Formerly known as Merck Limited, the company underwent a name change in May 2019 to Procter & Gamble Health Limited. Since its inception in 1967, the company has been headquartered in Mumbai, India. Procter & Gamble Health Limited operates as a subsidiary of Procter & Gamble Overseas India B.V., further strengthening its global presence and leveraging the expertise of its parent company.

Company name	Listing date	Industry	NSE symbol BSE symbol
Procter & Gamble Health Limited	Apr, 1996 Jan, 1982	Pharmaceuticals Pharmaceuticals	PGHL PGHL

Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022

Promoters

51.82%
Public

48.18%
Shares held by Employee Trusts

0.00%
Promoters

51.82%
Public

48.18%
Shares held by Employee Trusts

0.00%
Promoters

51.82%
Public

48.18%
Shares held by Employee Trusts

0.00%
Promoters

51.82%
Public

48.18%
Shares held by Employee Trusts

0.00%
Promoters

51.82%
Public

48.18%
Shares held by Employee Trusts

0.00%

Promoters
	51.82%

Public
	48.18%

Shares held by Employee Trusts
	0.00%

Promoters
	51.82%

Public
	48.18%

Shares held by Employee Trusts
	0.00%

Promoters
	51.82%

Public
	48.18%

Shares held by Employee Trusts
	0.00%

Promoters
	51.82%

Public
	48.18%

Shares held by Employee Trusts
	0.00%

Promoters
	51.82%

Public
	48.18%

Shares held by Employee Trusts
	0.00%

Procter & Gamble Health Limited FAQ's

What is the range of today's stock performance for Procter & Gamble Health Limited?

Today's stock performance witnessed a fluctuation from a minimum of 5,555.00 on the NSE (National Stock Exchange) to a maximum of 5,642.45. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 5,538.25 to a high of 5,637.40.

What are the 52-week low and high values for Procter & Gamble Health Limited?

The stock's performance over the past 52 weeks reveals a low of 4,636.55 (occurred on 25-Apr-2024) and a high of 5,833.30 (achieved on 06-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 4,640.30 (on 09-May-2024), and the 52-week high is 5,835.95 (on 06-Nov-2024).

What was the opening and previous closing prices for Procter & Gamble Health Limited?

The stock's performance over the past 52 weeks reveals a low of 4,636.55 (occurred on 25-Apr-2024) and a high of 5,833.30 (achieved on 06-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 4,640.30 (on 09-May-2024), and the 52-week high is 5,835.95 (on 06-Nov-2024).

What is the total volume and traded value for Procter & Gamble Health Limited for the day?

The total volume is 0, and the total traded value is 3.28 (₹ Lakhs).

What are the upper and lower circuit limits for Procter & Gamble Health Limited?

The upper circuit limit is 6,770.40, and the lower circuit limit is 4,513.60.

What is the market cap and PE ratio for Procter & Gamble Health Limited?

The market cap is ₹93.12 Cr, and the PE ratio (TTM) is 43.01.

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Procter & Gamble Health Limited?

ROE is 40.45, EPS is 131.17, book value is not available

What are the revenue and profit figures for the latest quarter and previous quarters for Procter & Gamble Health Limited?

In Sep 2023, Revenue is ₹3049300000.00, and Profit is ₹655700000.00. In Jun 2023, Revenue is ₹3011800000.00, and Profit is ₹298200000.00.

When was Procter & Gamble Health Limited listed, and what industry does it belong to?

The company, Procter & Gamble Health Limited, was listed in Apr 1996 and belongs to the Pharmaceuticals industry. Its NSE symbol is PGHL.

What is the current shareholding pattern of the Procter & Gamble Health Limited?

As of latest available update, promoters hold 51.82%, the public holds 48.18%, and Employee Trusts holds 0.00.

Search

Navigation section